BEST3 and type 2 diabetes mellitus: Notably, in islets from T2D cases, BEST3 had 50% lower expression and three sites with increased methylation in a region near the TSS known to be bound by MAFB, NKX2.2, and PDX1 (Supplementary Fig. 3h).